-
The prices of these Chinese medicinal materials have increased (list attached)
Time of Update: 2021-04-23
Medical Network News on April 20 The prices of these Chinese medicines are rising Yesterday, the Pharmaceutical News Agency released the ranking list of Chinese medicinal materials price increase as of April 18 in Bozhou market.
-
Hisun Pharmaceutical Tofacitib Citrate Tablets Obtained Drug Registration Certificate
Time of Update: 2021-04-23
Hisun Pharmaceutical's tofacitib citrate tablets were approved by the State Food and Drug Administration according to the new category 4, and they were deemed to have passed the consistency evaluation.
-
Merck announces data on the efficacy of ATR inhibitor berzosertib in the treatment of small cell lung cancer
Time of Update: 2021-04-23
The results of a phase II proof-of-concept study (NCT02487095) conducted by the National Cancer Institute (NCI) showed that in patients with recurrent small cell lung cancer (SCLC), berzosertib combined with the chemotherapy drug topotecan is objective The response rate (ORR) was 36% (95% CI: 18.
-
The difference between Liuwei Dihuang Wan and Zhibai Dihuang Wan
Time of Update: 2021-04-23
So, what is the difference between Liuwei Dihuang Wan and Zhibai Dihuang Wan?Although both drugs belong to the traditional classic prescriptions for nourishing yin and tonifying the kidney, there are differences in clinical application due to the difference in the ingredients of the drugs.
-
The fifth batch of national procurement reports: 60 varieties are involved, more than half of the injections!
Time of Update: 2021-04-23
Medical Network, April 16 News On April 15, the "Notice on Reporting the Purchasing Data of the Fifth Batch of National Organizations for Centralized Procurement of Drugs" circulated in the industry, which means that the fifth batch of national procurement officially kicked off.
-
Five ways to focus on monitoring drugs!
Time of Update: 2021-04-23
Open up a "second battlefield" For pharmaceutical companies, the restricted use of drugs due to key monitoring, ranging from a sharp decline in sales performance, to a rupture of the capital chain and falling to death.
-
The state's multi-sectoral joint "bright sword" to unreasonable medical inspections!
Time of Update: 2021-04-23
The actions specifically include five key contents: The first is to control the conduct of medical inspections in violation of laws and regulations.
The actions specifically include five key contents: The first is to control the conduct of medical inspections in violation of laws and regulations.
-
More than 11 million hits and floats Haizheng Pharmaceutical's withdrawal of a generic drug listing application
Time of Update: 2021-04-23
On November 7, 2017, Hanhui Pharmaceutical submitted an application for the registration of irbesartan hydrochlorothiazide tablets to Zhejiang Food and Drug Administration according to category 4 of chemical drug registration classification and was accepted.
-
Panlong Pharmaceutical cancels its wholly-owned subsidiary
Time of Update: 2021-04-23
According to the 2020 annual performance report of Panlong Group, during the reporting period, the company achieved operating income of 670,058,900 yuan, an increase of 9.
73% over the same period of the previous year; realized operating profit of 90,465,200 yuan, an increase of 4.
-
Arnold Pharma announces the completion of the first patient dosing for Buparlisib's global phase III clinical trial
Time of Update: 2021-04-23
On April 15th, Arnold Pharma announced that its oral PI3K inhibitor Buparlisib (AN2025) combined with paclitaxel for the treatment of recurrent or metastatic head and neck squamous cell carcinoma in the global multi-center phase III clinical trial has been successful in Shanghai Oriental Hospital, China Complete the first patient's administration.
-
Pharmaceutical companies are named again for sales with gold
Time of Update: 2021-04-23
According to the above article, Liu Feng, the second-level inspector of the Bureau of Supervision and Evaluation of the Ministry of Finance, summarized from three aspects: “After inspection, he found out the cause of the falsely high drug prices, and deterred the illegal behavior of pharmaceutical companies to sell money and drive up prices.
-
Kangmei Pharmaceuticals exploded again!
Time of Update: 2021-04-23
Kangmei Pharmaceutical was listed on the Shanghai Stock Exchange in 2001, with a listed market value of less than 900 million.
-
The licensed pharmacist country has begun to issue subsidies
Time of Update: 2021-04-23
The announcement showed that, in accordance with the spirit of the relevant documents, the Baoji City Social Insurance Management Center approved the grant of technical skill improvement subsidies to 442 employees of enterprises and institutions including Zhang Hua.
-
Announcement of annual results of Machinery Enterprise: Weigao, MicroPort, Yuyue...
Time of Update: 2021-04-23
2500%， ，iFinD，412，332020。 ，，2020，。 ，、，202047. 63，1203. 53%；26. 17，6527. 90%。 ，、、。 2020138. 37，564. 29%；70. 07，3829. 56%。，。 Previously, in the 2020 annual report performance forecast disclosed
-
Yangzijiang Pharmaceutical was fined 764 million yuan for implementing the monopoly agreement!
Time of Update: 2021-04-23
The above-mentioned actions of Yangtze River Pharmaceutical Group have eliminated and restricted competition, harmed the legitimate rights and interests of consumers and the public interest, and violated Article 14 of the Anti-Monopoly Law, which prohibits operators and counterparties from reaching the following monopoly agreements: (1) Fixed The price for resale of commodities to third parties; (2) The provisions of limiting the minimum price for reselling commodities to third parties.
-
State Council: Let go of the prescription drug sales online!
Time of Update: 2021-04-23
(Ministry of Civil Affairs, National Health Commission, State Drug Administration and other relevant departments of the State Council and various regions are responsible according to the division of responsibilities) Among them, “on the premise of ensuring the authenticity and reliability of the source of electronic prescriptions, online sales of prescription drugs other than those under special state management are allowed.
-
Yuheng Pharmaceutical's Lugua Polypeptide was withdrawn from the Internet!
Time of Update: 2021-04-23
According to the requirements of the notice, since the date when the provincial medicine price and credit evaluation system for recruitment and procurement takes effect, pharmaceutical companies participating in or entrusting to participate in centralized procurement, online procurement, and filing procurement of drugs and medical consumables must submit a trustworthy commitment.
-
"Barrier Free" Circulation in the Medical Union!
Time of Update: 2021-04-23
The document clearly stated that for traditional Chinese medicine preparations with definite curative effect, reliable quality, approved documents, still within the validity period, and clinically safe use for more than 2 years, "barrier-free" adjustments and use in the provincial medical association are allowed.
-
The drug dealer issued a notice: a "4+7" quantity-collected product, difficult to purchase
Time of Update: 2021-04-23
For example, Hubei announced that the national organization of centralized drug procurement pilot expansion (Hubei) paroxetine oral constant-release dosage form and other 8 varieties of selected results also include dexmedetomidine hydrochloride injection.
-
Pharmacies in Shanxi Province will resume sales of antipyretic drugs from April 16th
Time of Update: 2021-04-23
Medical Network News, April 19 Since April 16, pharmacies in Shanxi Province have resumed sales of antipyretic drugs. With immediate effect, pharmacies resume sales According to the "Notice on Str
